Specific Detection of Pathological Three‐repeat Tau after Pretreatment with Potassium Permanganate and Oxalic Acid in PSP/CBD Brains

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Brain Pathology

• Publication date

  2011-03-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1111/j.1750-3639.2010.00433.xPMID 20825412PMCID PMC8094262
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The Effect of Prolonged Fixation Time on Immunohistochemical Staining of Common Neurodegenerative Disease Markers

  2010cited by this paper
• Does Alzheimer's disease begin in the brainstem?

  2009cited by this paper
• Selective Deposition of 4-Repeat Tau in Cerebral Infarcts

  2009cited by this paper
• Silver diagnosis in neuropathology: principles, practice and revised interpretation

  2007cited by this paper
• Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry

  2006cited by this paper
• An immunohistochemical study of cases of sporadic and inherited frontotemporal lobar degeneration using 3R- and 4R-specific tau monoclonal antibodies

  2006cited by this paper
• Cellular tau pathology and immunohistochemical study of tau isoforms in sporadic tauopathies

  2006cited by this paper
• Characteristics of two distinct clinical phenotypes in pathologically proven progressive supranuclear palsy: Richardson's syndrome and PSP-parkinsonism.

  2005cited by this paper
• Detecting tau isoforms in archival cases

  2004cited by this paper
• Abnormal cytoskeletal pathology peculiar to corticobasal degeneration is different from that of Alzheimer's disease or progressive supranuclear palsy

  2004cited by this paper
• Differential involvement and heterogeneous phosphorylation of tau isoforms in progressive supranuclear palsy.

  2004cited by this paper
• Monoclonal antibodies with selective specificity for Alzheimer Tau are directed against phosphatase-sensitive epitopes

  2004cited by this paper
• Pathological inclusion bodies in tauopathies contain distinct complements of tau with three or four microtubule‐binding repeat domains as demonstrated by new specific monoclonal antibodies

  2003influential reference
• Selective Neurofibrillary Degeneration of the Hippocampal CA2 Sector Is Associated with Four‐Repeat Tauopathies

  2002cited by this paper
• The complex relationship between soluble and insoluble tau in tauopathies revealed by efficient dephosphorylation and specific antibodies

  2002cited by this paper
• Validity and Reliability of the Preliminary NINDS Neuropathologic Criteria for Progressive Supranuclear Palsy and Related Disorders

  1996cited by this paper
• Alzheimer-type pathology in melanin-bleached sections of substantia nigra

  1995cited by this paper
• Preliminary NINDS neuropathologic criteria for Steele‐Richardson‐Olszewski syndrome (progressive supranuclear palsy)

  1994cited by this paper
• TRICHOXANTHIN, THE YELLOW GRANULAR PIGMENT OF GUINEA PIG HAIR FOLLICLES AND HAIRS

  1957cited by this paper

• Identification of high-performing antibodies for the reliable detection of Tau proteoforms by Western blotting and immunohistochemistry

  2024cites this paper
• Tau seeds from patients induce progressive supranuclear palsy pathology and symptoms in primates.

  2022cites this paper
• Neuronal internalization of immunoglobulin G injected into the mouse brain by a novel absorption strategy to avoid unwanted interaction with immune complex using centrifugal filtration

  2022cites this paper
• Cholesterol-functionalized DNA/RNA heteroduplexes cross the blood–brain barrier and knock down genes in the rodent CNS

  2021cites this paper
• Neurofibrillary changes undergoing morphological and biochemical changes – How does tau with the profile shift of from four repeat to three repeat spread in Alzheimer brain?

  2020cites this paper
• Astrocytic 3-Repeat Tau Pathologies in Progressive Supranuclear Palsy.

  2020cites this paper
• Atypical globular glial tauopathy with a combination of types I and II pathology

  2019cites this paper
• Astrocytic tau pathologies in aged human brain

  2019cites this paper
• Detection of AD-specific four repeat tau with deamidated asparagine residue 279-specific fraction purified from 4R tau polyclonal antibody

  2019cites this paper
• How to demix Alzheimer-type and PSP-type tau lesions out of their mixture -hybrid approach to dissect comorbidity-

  2019cites this paper
• Cellular and regional vulnerability in frontotemporal tauopathies

  2019cites this paper
• Title : Brainstem tau pathology in Alzheimer ’ s disease is characterized by increase of three repeat tau and independent of amyloid β Author Names

  2019cites this paper
• Tau Filaments and the Development of Positron Emission Tomography Tracers

  2018cites this paper
• Adult moyamoya disease associated with abundant phosphorylated tau accumulation in the brainstem: Report of a case with autopsy findings

  2018cites this paper
• Brainstem tau pathology in Alzheimer’s disease is characterized by increase of three repeat tau and independent of amyloid β

  2018cites this paper
• Three-Repeat Tau with Grain-Like Structures and Distribution in an 83-Year-Old Man

  2017cites this paper
• Pathological Tau Strains from Human Brains Recapitulate the Diversity of Tauopathies in Nontransgenic Mouse Brain

  2017cites this paper
• Tau pathology in aged cynomolgus monkeys is progressive supranuclear palsy/corticobasal degeneration- but not Alzheimer disease-like -Ultrastructural mapping of tau by EDX-

  2016cites this paper
• A Naturally Occurring Bovine Tauopathy Is Geographically Widespread in the UK

  2015influential citation
• The Pattern of Lesions During the Transition to the Symptomatic Phase and in Fully Developed Alzheimer’s Disease

  2015cites this paper
• An autopsied case of corticobasal degeneration showing severe cerebral atrophy over a protracted disease course of 16 years

  2015cites this paper
• Microtubules and the Protein Tau

  2015cites this paper
• Invited review: Neuropathology of tauopathies: principles and practice

  2015cites this paper
• An autopsy case of incipient Pick's disease: Immunohistochemical profile of early‐stage Pick body formation

  2014cites this paper
• Pretangles and neurofibrillary changes: Similarities and differences between AD and CBD based on molecular and morphological evolution

  2014cites this paper
• Glial and neuronal tau pathology in tauopathies: characterization of disease-specific phenotypes and tau pathology progression.

  2014cites this paper
• Reply: the early pathological process in sporadic Alzheimer’s disease

  2013cites this paper
• Four-repeat tau-selective deposition in subthalamic nucleus and motor cortex in Alzheimer disease.

  2013cites this paper
• Cellular minigene models for the study of allelic expression of the tau gene and its role in progressive supranuclear palsy

  2013cites this paper
• Isoform transition from four-repeat to three-repeat tau underlies dendrosomatic and regional progression of neurofibrillary pathology

  2013cites this paper
• LRRK2 I2020T mutation is associated with tau pathology.

  2012cites this paper
• Abnormal tau deposition in neurons, but not in glial cells in the cerebral tissue surrounding arteriovenous malformation

  2012cites this paper
• Expanding morphological dimensions in neuropathology, from sequence biology to pathological sequences and clinical consequences

  2011cites this paper
• Tangle evolution linked to differential 3- and 4-repeat tau isoform deposition: a double immunofluorolabeling study using two monoclonal antibodies

  2011cites this paper